News and Events – Page 3 – George Clinical

George Clinical Congratulates Parent Company The George Institute For Global Health For Securing $12 Million To Tackle Worlds Biggest Killers

[Sydney, Australia] George Clinical congratulates its parent company, The George Institute for Global Health for securing $12 million from the National Health and Medical Research Council (NHMRC), Australia’s peak funding body for medical research. These grants will support The Institute’s scientific leaders to improve the lives of people living with chronic kidney disease, septic shock […]

February 12th, 2019

George Clinical’s Parent Company The George Institute For Global Health Secures Largest Ever NHMRC Project Grant To Benefit People With Kidney Disease

George Clinical congratulates its parent company, The George Institute for Global Health for securing a project grant that could transform the treatment of chronic kidney disease (CKD) globally and benefit millions of people globally. The $5.5 million awarded by the National Health and Medical Research Council (NHMRC), Australia’s peak funding body for medical research, is […]

February 5th, 2019

George Clinical Scientific Leader research contributions recognized with leading Lancet profile.

George Clinical welcomes the recognition of Professor Craig Anderson as profiled in the premier medical journal The Lancet which identified him as “a front runner in stroke research”. “It is our engagement with scientific leaders, such as Professor Anderson, that sets George Clinical apart from other CROs,” said Philip Gregory, Managing Director, China. “The Lancet […]

January 29th, 2019

George Clinical Welcomes WCC Partnership with OneOncology

George Clinical welcomes the recent announcement by our partner organization, West Cancer Center of their intention to join OneOncology in January 2019. The announcement sees a departure from their existing relationship with Methodist Le Bonheur Healthcare, an affiliation they have held since 2011. The affiliation with OneOncology will place West Cancer Center as a nationally […]

January 29th, 2019

George Clinical announces the appointment of James Cheong to the role of Chief Operating Officer

SYDNEY, January 22, 2019 – George Clinical, headquartered in Sydney, Australia, a global scientifically backed CRO, today announced the appointment of James Cheong to the role of Chief Operating Officer. With extensive management experience spanning over two decades, Cheong brings valuable leadership to George Clinical’s executive team during a period of strong expansion and growth. […]

January 22nd, 2019

Taiwan’s Pragmatic Timelines Make it a ‘Top-Tier’ Country for MRCTs

By George Clinical
Industry News

George Clinical welcomes The Taiwan Food and Drug Administration’s (TFDA) recent clarified timelines for approval of a general Clinical Trial Authority (CTA) at 45 calendar days. The announcement, released by the TFDA in October, adds to the suite of attractive options to expedite clinical trial regulatory approval timelines in Taiwan. This includes the existing 15 […]

January 8th, 2019

Established Investigator Networks Are Central to the Strength of the Clinical Trial Environment

By George Clinical
Industry News

The importance of securing strong, long-standing investigator networks with leading research hospitals and clinics is critical to the continued growth of the clinical trial environment in countries such as Taiwan, says Evon Hui, Head of Business Operations, East Asia. Over the past 15 years, George Clinical has cultivated an enviable network of MOUs that have […]

January 6th, 2019

George Clinical Recognized with Employer Award by Hong Kong Authority

George Clinical, a leading clinical research organization (CRO) in the Asia-Pacific region, has gained recognition of the organization’s strong support of the Mandatory Provident Fund (MPF) legislation, and their provision of good MPF benefits. The Mandatory Provident Fund Schemes Authority (MPFA) awarded George Clinical their Good MPF Employer Award at a ceremony in Hong Kong […]

January 5th, 2019

George Clinical Scientific Leader Jason Chandler Sees Approval of New Therapy

By George Clinical
Industry News

George Clinical welcomes the decision by the FDA to approve the delivery of CAR-T therapy in a partnership between Methodist Healthcare, and George Clinical Scientific Leader, Dr. Jason Chandler of West Cancer Center. Car-T therapies are at the cutting edge of treatment for a range of cancers. The recent announcement by the FDA, West Cancer […]

January 4th, 2019

Heart Health Research Center provides extensive research training and investigator networks to leading CRO George Clinical

By George Clinical
Industry News

Beijing, November 13, 2018 – George Clinical, a leading clinical research organization (CRO) in the Asia-Pacific region, has continued its involvement and collaboration with the Heart Health Research Center (HHRC), further developing the depth and quality of investigator networks. The HHRC, a collaborative initiative developed by Cardio Union, an emerging multi-disciplinary healthcare organization and the […]

December 6th, 2018